ALYFTREK FDA approval date

The FDA approved ALYFTREK on 20 Dec 2024.

FDA approval date
20 Dec 2024

Drug identity has not yet been verified against registry records

Also recorded as DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-12-20DayALYFTREKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218730", "applicant_as_listed_by_fda": "VERTEX PHARMS INC", "brand_names": ["ALYFTREK"], "active_ingredients": ["DEUTIVACAFTOR", "TEZACAFTOR", "VANZACAFTOR CALCIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20241220", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026